this interview is great.
https://www.******.com.au/media/the-aussie-medtech-securing-the-first-new-us-alzheimers-treatment-in-18-years?videoId=11047
in terms of cash management, am I day dreaming? he talked about capital management may be considered next FY. so there is hope that as cash flow improves with increasing clinical trial activities as well as Eisai partnership, we might be talking about ... dare I say the word... dividend?
5 Weeks until Aducanumab PDUFA date, page-34
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
0.010(1.10%) |
Mkt cap ! $157.9M | |||
| Open | High | Low | Value | Volume |
| 91.0¢ | 92.5¢ | 90.5¢ | $43.31K | 47.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8224 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.59pm 07/10/2024 (20 minute delay) ? |
| CGS (ASX) Chart |